Tags

Type your tag names separated by a space and hit enter

Longitudinal study on the role of body size in premenopausal breast cancer.
Arch Intern Med 2006; 166(21):2395-402AI

Abstract

BACKGROUND

A high body mass index (BMI) has been related to a reduced risk of breast cancer in premenopausal women. The mechanisms underlying this association have not been elucidated.

METHODS

We explored whether factors affecting ovulation may explain the inverse association between BMI (calculated as weight in kilograms divided by the square of height in meters) and breast cancer in 113,130 premenopausal participants in the Nurses' Health Study II. During 1,225,520 person-years of prospective follow-up between 1989 and 2003, 1398 incident cases of invasive breast cancer were diagnosed. Weight, height, ovulatory infertility, menstrual cycle patterns, and a multitude of covariates were assessed throughout follow-up. Cox proportional hazards regression was used to compute hazard ratios and 95% confidence intervals (CIs).

RESULTS

We observed a significant linear inverse trend between current BMI and breast cancer incidence (P<.001) that was not explained by menstrual cycle characteristics or infertility due to an ovulatory disorder (covariate-adjusted hazard ratio for breast cancer in women with a BMI > or =30 vs 20.0-22.4, 0.81; 95% CI, 0.68-0.96). We found BMI at age 18 years to be the strongest predictor of breast cancer incidence (covariate-adjusted hazard ratio for breast cancer in women with a BMI at age 18 years > or =27.5 vs 20.0-22.4, 0.57; 95% CI, 0.41-0.81).

CONCLUSIONS

Body size during the early phases of adult life seems to be particularly important in the development of premenopausal breast cancer. Factors other than anovulation are likely to mediate the protection conferred by a high BMI.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17130395

Citation

Michels, Karin B., et al. "Longitudinal Study On the Role of Body Size in Premenopausal Breast Cancer." Archives of Internal Medicine, vol. 166, no. 21, 2006, pp. 2395-402.
Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395-402.
Michels, K. B., Terry, K. L., & Willett, W. C. (2006). Longitudinal study on the role of body size in premenopausal breast cancer. Archives of Internal Medicine, 166(21), pp. 2395-402.
Michels KB, Terry KL, Willett WC. Longitudinal Study On the Role of Body Size in Premenopausal Breast Cancer. Arch Intern Med. 2006 Nov 27;166(21):2395-402. PubMed PMID: 17130395.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Longitudinal study on the role of body size in premenopausal breast cancer. AU - Michels,Karin B, AU - Terry,Kathryn L, AU - Willett,Walter C, PY - 2006/11/30/pubmed PY - 2007/1/16/medline PY - 2006/11/30/entrez SP - 2395 EP - 402 JF - Archives of internal medicine JO - Arch. Intern. Med. VL - 166 IS - 21 N2 - BACKGROUND: A high body mass index (BMI) has been related to a reduced risk of breast cancer in premenopausal women. The mechanisms underlying this association have not been elucidated. METHODS: We explored whether factors affecting ovulation may explain the inverse association between BMI (calculated as weight in kilograms divided by the square of height in meters) and breast cancer in 113,130 premenopausal participants in the Nurses' Health Study II. During 1,225,520 person-years of prospective follow-up between 1989 and 2003, 1398 incident cases of invasive breast cancer were diagnosed. Weight, height, ovulatory infertility, menstrual cycle patterns, and a multitude of covariates were assessed throughout follow-up. Cox proportional hazards regression was used to compute hazard ratios and 95% confidence intervals (CIs). RESULTS: We observed a significant linear inverse trend between current BMI and breast cancer incidence (P<.001) that was not explained by menstrual cycle characteristics or infertility due to an ovulatory disorder (covariate-adjusted hazard ratio for breast cancer in women with a BMI > or =30 vs 20.0-22.4, 0.81; 95% CI, 0.68-0.96). We found BMI at age 18 years to be the strongest predictor of breast cancer incidence (covariate-adjusted hazard ratio for breast cancer in women with a BMI at age 18 years > or =27.5 vs 20.0-22.4, 0.57; 95% CI, 0.41-0.81). CONCLUSIONS: Body size during the early phases of adult life seems to be particularly important in the development of premenopausal breast cancer. Factors other than anovulation are likely to mediate the protection conferred by a high BMI. SN - 0003-9926 UR - https://www.unboundmedicine.com/medline/citation/17130395/Longitudinal_study_on_the_role_of_body_size_in_premenopausal_breast_cancer_ L2 - https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/archinte.166.21.2395 DB - PRIME DP - Unbound Medicine ER -